Crinetics Pharmaceuticals Inc (CRNX) stock has gained 64.39% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CRNX stock a score of 72 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 99. CRNX's rank also includes a short-term technical score of 64.
CRNX has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on CRNX!
Crinetics Pharmaceuticals Inc (CRNX) stock is lower by -2.81% while the S&P 500 has gained 0.01% as of 12:23 PM on Thursday, Nov 9. CRNX is lower by -$0.80 from the previous closing price of $28.45 on volume of 135,231 shares. Over the past year the S&P 500 is higher by 16.93% while CRNX has gained 64.39%. CRNX lost -$3.41 per share in the over the last 12 months.
Click Here to get the full Stock Report for Crinetics Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
